VT News
  • Home
  • Lopsided
  • Local News
  • Timelines

23Serious

Mon, Jul 14, 2025
12:55 AM
Daily Index

Negative

23Serious

Neutral

Optimistic

Positive

Negative

23Serious

Neutral

Optimistic

Positive

Negative

23Serious

Neutral

Optimistic

Positive

Coverage Details
Total News Sources
1
Left
0
Center
0
Right
1
Unrated
0
Last Updated
152 days ago
Bias Distribution
100% Right
154 days ago
Updated 152 days ago
Alzheimer's Drugs Face Scrutiny Amid Treatment Challenges
Alzheimer's Drugs Face Scrutiny Amid Treatment Challenges

Alzheimer's Drugs Face Scrutiny Amid Treatment Challenges

News summary

Recent developments in Alzheimer's research highlight both challenges and hopeful advancements. A systematic review revealed that certain medications, such as antimicrobials and vaccines, may reduce the risk of Alzheimer's, while antipsychotics and diabetes drugs could increase it. Meanwhile, the Scottish Medicines Consortium faced criticism for not approving the Alzheimer's drug lecanemab, citing modest clinical benefits and cost concerns, which has been described as a 'heartbreaking setback' for patients. In contrast, Eli Lilly is initiating a clinical trial for the anti-amyloid drug remternetug, targeting individuals at risk for familial Alzheimer's, marking a shift towards early intervention. However, concerns persist regarding the safety of existing treatments, as evidenced by a tragic case where a patient suffered severe complications potentially linked to lecanemab. The overall landscape suggests a pressing need for effective treatment options and better diagnostic practices as the Alzheimer's patient population continues to grow.

Story Coverage
alt
Daily Mail
Right
We're treating Alzheimer's with risky drugs: CHARLES PILLER
154 days ago
Read Full Article
alt
Daily Mail
Right
We're treating Alzheimer's with risky drugs: CHARLES PILLER
154 days ago
Read Full Article
Bias Distribution
100% Right
Information Sources
605a98c4-d25e-430b-86c1-9232b14faa6b
Right 100%
Coverage Details
Total News Sources
1
Left
0
Center
0
Right
1
Unrated
0
Last Updated
152 days ago
Bias Distribution
100% Right
Related News
Daily Index

Negative

23Serious

Neutral

Optimistic

Positive

Negative

23Serious

Neutral

Optimistic

Positive

Negative

23Serious

Neutral

Optimistic

Positive

Ask VT AI
Story Coverage
alt
Daily Mail
Right
We're treating Alzheimer's with risky drugs: CHARLES PILLER
154 days ago
Read Full Article
alt
Daily Mail
Right
We're treating Alzheimer's with risky drugs: CHARLES PILLER
154 days ago
Read Full Article
Ask VT AI
Bias Distribution
100% Right
Information Sources
605a98c4-d25e-430b-86c1-9232b14faa6b
Right 100%
Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Present

Gift Subscriptions

The perfect gift for understanding
news from all angles.

Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Present

Gift Subscriptions

The perfect gift for understanding
news from all angles.

Related News
Recommended News
  • Home
  • My feed
  • Lopsided

Top Topics

Trending in U.S.

World

Sport

VT News
VT News

VTNews.ai © 2025
All Rights Reserved

Cookie Policy
We use cookies to personalize content and ads, to provide social media features, and to analyze our traffic. We also share information about your use of our site with our social media, advertising, and analytics partners.
By continuing to use our site, you consent to our cookies. You can manage your preferences or withdraw your consent at any time by clicking on the buttons below.